Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 258Lung Neoplasms 207Adenocarcinoma of Lung 44Small Cell Lung Carcinoma 31Adenocarcinoma, Bronchiolo-Alveolar 23Brain Neoplasms 17Breast Neoplasms 14Neoplasm Metastasis 12Mesothelioma, Malignant 10Radiation Injuries 8Neoplasms 8Prostatic Neoplasms 7Melanoma 7Thymoma 6Squamous Cell Carcinoma of Head and Neck 6NSCLC 6Head and Neck Neoplasms 6Drug-Related Side Effects and Adverse Reactions 6Carcinoma, Renal Cell 6Pancreatic Neoplasms 4Esophageal Neoplasms 4Advanced NSCLC 4Urinary Bladder Neoplasms 3Salivary Gland Neoplasms 3Rectal Neoplasms 3Kidney Neoplasms 3Esthesioneuroblastoma, Olfactory 3Colorectal Neoplasms 3Carcinoma, Squamous Cell 3Thyroid Neoplasms 2

Interventions

Radiotherapy 1Etoposide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
ES-SCLC × Radiotherapy × Thoracic × Clear all
NCT07349225 2026-01-16

Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

The Second Affiliated Hospital of Dalian Medical University

Phase 2 Not yet recruiting
46 enrolled
Thoracic

ES-SCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡